You have 9 free searches left this month | for more free features.

entrectinib

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Uveal Melanoma Trial in Minneapolis (PAC-1, Entrectinib)

Recruiting
  • Uveal Melanoma
  • Minneapolis, Minnesota
    HealthPartners Institute Regions Cancer Care Center
Jan 10, 2022

Hepatic Insufficiency Trial in Praha 7, Miskolc, Bratislava (entrectinib)

Completed
  • Hepatic Insufficiency
  • entrectinib
  • Praha 7, Czechia
  • +2 more
Jan 14, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 25, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Korea, Republic of, United States (Entrectinib)

Completed
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Entrectinib
  • Orange, California
  • +9 more
Jun 7, 2021

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

NSCLC Trial in Worldwide (Entrectinib, Crizotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Barretos, SP, Brazil
  • +51 more
Jul 26, 2022

Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

Recruiting
  • Solid Tumors
  • CNS Tumors
  • Entrectinib
  • Orange, California
  • +38 more
Aug 24, 2022

NSCLC Trial in Worldwide (Alectinib, Entrectinib, Pralsetinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • San José, Costa Rica
  • +3 more
Aug 4, 2022

ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

Terminated
  • ALK Fusion Protein Expression
  • +14 more
  • San Francisco, California
    University of California, San Francisco
Jan 14, 2020

Cancers With NTRK, ROS1, or ALK Gene Fusions Trial in San Diego (Entrectinib)

No longer available
  • Cancers With NTRK, ROS1, or ALK Gene Fusions
  • Entrectinib
  • San Diego, California
    1-844-Startrk (782-7875)
Apr 24, 2019

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Entrectinib
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Advanced Solid Tumor Trial in Denver, Sarasota, Nashville (Entrectinib, Midazolam Hydrochloride)

Completed
  • Advanced Solid Tumor
  • Entrectinib
  • Midazolam Hydrochloride
  • Denver, Colorado
  • +2 more
Aug 17, 2018

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)

Recruiting
  • Advanced Unresectable or Metastatic Solid Malignancy
  • Entrectinib
  • +11 more
  • Birmingham, Alabama
  • +50 more
Aug 10, 2022

Cancer of Unknown Primary Site Trial in Worldwide (Alectinib, Vismodegib, Ipatasertib)

Recruiting
  • Cancer of Unknown Primary Site
  • Blacktown, New South Wales, Australia
  • +161 more
Jul 25, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022